Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
or

Royalty Pharma Plc Cl A (RPRX)

Royalty Pharma Plc Cl A (RPRX)
30.00 x 9 33.00 x 1
Post-market by (Cboe BZX)
31.21 -1.06 (-3.28%) 04/10/25 [NASDAQ]
30.00 x 9 33.00 x 1
Post-market 31.21 unch (unch) 17:21 ET
Quote Overview for Thu, Apr 10th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
30.31
Day High
31.97
Open 31.97
Previous Close 32.27 32.27
Volume 6,600,600 6,600,600
Avg Vol 5,274,860 5,274,860
Stochastic %K 39.81% 39.81%
Weighted Alpha +13.72 +13.72
5-Day Change -0.58 (-1.82%) -0.58 (-1.82%)
52-Week Range 24.05 - 34.20 24.05 - 34.20
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 18,602,138
  • Shares Outstanding, K 576,453
  • Annual Sales, $ 2,264 M
  • Annual Income, $ 858,980 K
  • EBIT $ 1,292 M
  • EBITDA $ 1,312 M
  • 60-Month Beta 0.50
  • Price/Sales 7.85
  • Price/Cash Flow 7.35
  • Price/Book 1.76

Options Overview Details

View History
  • Implied Volatility 57.94% ( +14.04%)
  • Historical Volatility 28.75%
  • IV Percentile 99%
  • IV Rank 94.36%
  • IV High 60.71% on 04/07/25
  • IV Low 11.67% on 08/19/24
  • Put/Call Vol Ratio 4.94
  • Today's Volume 939
  • Volume Avg (30-Day) 1,426
  • Put/Call OI Ratio 0.29
  • Today's Open Interest 42,230
  • Open Int (30-Day) 38,036

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 6 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate 1.02
  • Number of Estimates 3
  • High Estimate 1.04
  • Low Estimate 1.00
  • Prior Year 0.98
  • Growth Rate Est. (year over year) +4.08%

Price Performance

See More
Period Period Low Period High Performance
1-Month
29.66 +5.23%
on 04/07/25
Period Open: 32.75
34.14 -8.58%
on 03/25/25
-1.54 (-4.70%)
since 03/10/25
3-Month
29.66 +5.23%
on 04/07/25
Period Open: 29.49
34.20 -8.74%
on 02/24/25
+1.72 (+5.83%)
since 01/10/25
52-Week
24.05 +29.77%
on 12/19/24
Period Open: 29.45
34.20 -8.74%
on 02/24/25
+1.76 (+5.98%)
since 04/10/24

Most Recent Stories

More News
Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know

Omnicell, Royalty Pharma, EXL, IMAX, and OPENLANE Stocks Trade Down, What You Need To Know

OMCL : 31.08 (-4.93%)
RPRX : 31.21 (-3.28%)
IMAX : 22.03 (-6.02%)
EXLS : 44.02 (-2.11%)
KAR : 18.32 (-3.22%)
Royalty Pharma Appoints Vlad Coric, M.D. to the Company’s Board of Directors

RPRX : 31.21 (-3.28%)
A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

A Look Back at Branded Pharmaceuticals Stocks’ Q4 Earnings: Collegium Pharmaceutical (NASDAQ:COLL) Vs The Rest Of The Pack

RPRX : 31.21 (-3.28%)
COLL : 24.67 (-6.45%)
SUPN : 31.07 (-2.17%)
OGN : 11.43 (-9.57%)
ZTS : 147.00 (-4.27%)
4 Healthcare Stocks With Massive Gains—and More to Come

Healthcare is the top industry of 2025 so far. These healthcare companies have seen 30% increases in share prices since the beginning of the year.

AET : 212.70 (+0.33%)
CVS : 68.97 (-1.72%)
GH : 41.14 (-6.22%)
RPRX : 31.21 (-3.28%)
TEM : 40.29 (-7.99%)
Royalty Pharma Announces Upcoming Investor Day

RPRX : 31.21 (-3.28%)
3 Reasons to Sell RPRX and 1 Stock to Buy Instead

3 Reasons to Sell RPRX and 1 Stock to Buy Instead

META : 546.29 (-6.74%)
RPRX : 31.21 (-3.28%)
Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Highs And Lows: Royalty Pharma (NASDAQ:RPRX) Vs The Rest Of The Branded Pharmaceuticals Stocks

RPRX : 31.21 (-3.28%)
COLL : 24.67 (-6.45%)
SUPN : 31.07 (-2.17%)
OGN : 11.43 (-9.57%)
ZTS : 147.00 (-4.27%)
3 Value Stocks in Hot Water

3 Value Stocks in Hot Water

RPRX : 31.21 (-3.28%)
DLTR : 71.74 (-1.14%)
SCSC : 31.03 (-3.48%)
1 Stock Under $50 with Exciting Potential and 2 to Ignore

1 Stock Under $50 with Exciting Potential and 2 to Ignore

RPRX : 31.21 (-3.28%)
KRT : 24.63 (-1.20%)
GXO : 33.76 (-4.98%)
Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

Q4 Earnings Outperformers: Corcept (NASDAQ:CORT) And The Rest Of The Branded Pharmaceuticals Stocks

CORT : 67.73 (-7.18%)
RPRX : 31.21 (-3.28%)
SUPN : 31.07 (-2.17%)
OGN : 11.43 (-9.57%)
ZTS : 147.00 (-4.27%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Buy with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Royalty Pharma plc is a funder of biopharmaceutical industry. The compnay's portfolio includes royalties on commercial products, including AbbVie and J&J's Imbruvica, Astellas and Pfizer's Xtandi, Biogen's Tysabri, Gilead's HIV franchise, Merck's Januvia, Novartis' Promacta and Vertex's Kalydeco, Symdeko...

See More

Key Turning Points

3rd Resistance Point 33.68
2nd Resistance Point 32.82
1st Resistance Point 32.02
Last Price 31.21
1st Support Level 30.36
2nd Support Level 29.50
3rd Support Level 28.70

See More

52-Week High 34.20
Last Price 31.21
Fibonacci 61.8% 30.32
Fibonacci 50% 29.13
Fibonacci 38.2% 27.93
52-Week Low 24.05

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar